There is a great deal of overlap between CCND2, G1/S-specific cyclin D2, and STAT3, including the prolactin and FOXO signaling pathways, which are inactivated by major oncogenic signals such as the PI3K and MAPK pathways, and their expression is also repressed by microRNAs in multiple cancer types [24]. This evidence concerns the gene CCND2 and cancer.